Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group (Q71692527)
Jump to navigation
Jump to search
scientific article published on 01 October 1996
Language | Label | Description | Also known as |
---|---|---|---|
English | Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group |
scientific article published on 01 October 1996 |
Statements
Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group (English)
K McCoy
S Hamilton
1 October 1996